Translational research

Translational research projects encourage collaborations between basic and clinical research. Their goal is to study cells and their interactions with the environment, and in so doing to provide new impulses for novel therapies and clinical approaches in order to be able to act on the causes of cellular malfunction.  

Financial support for translational cancer research projects is possible thanks to:

"Allocated funds" - These funds are specifically created for each project. They come from private donations and must be used for the predetermined purpose. The Foundation guarantees that donations are used in full to finance the project to which they have been allocated.

“ISREC chairs” - These are created to offer young professors affiliated to the EPFL (School of Life Sciences - ISREC) or to a Swiss University (Faculty of biology or medicine) the opportunity to launch their career in research. They are financed by the fortune of the Foundation.

Translational research - ongoing projects

Immune-modulatory radiotherapy to enhance the effects of neo-adjuvant PD-L1 blockade after neo-adjuvant chemotherapy in patients with resectable stage III (N2) non-small cell lung cancer (NSCLC)

This “allocated fund in clinical research” was granted in December 2020 to Dr. Sacha Rothschild (University Hospital Basel) for 3 years.

More information

Translational study toward the development of a test for the early detection of primary breast cancer and breast cancer relapse

This "allocated fund” was awarded to Prof. Curzio Rüegg (University of Fribourg) in October 2020 for 4 years.

More information

Cancer Immunity in Context

This immune oncology chair was awarded to the research group of Prof. Mikaël Pittet (Laboratoire en immuno-oncologie/UNIGE/AGORA) in July 2019 for 10…

More information

News & Events

Posted on

A study led by Professors Hanahan, Zeng, Saghafinia and Chryplewicz has uncovered a protein overexpressed in numerous cancer types that suppresses the…

Read more
Posted on

We were very honored to welcome Federal Councilor Guy Parmelin to our annual conference on the challenges in cancer research.

This event was a great…

Read more
Posted on

Congratulations to Prof. Elisa Oricchio – ISREC Foundation Chair in Translational Oncology from 2014 to 2020 – appointed Director of the ISREC…

Read more
Posted on

In recognition of her exceptional commitment to scientific research, Prof. Susan M. Gasser, director of the ISREC Foundation, received an honorary…

Read more